TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.980
+0.010 (0.51%)
At close: Oct 8, 2025, 4:00 PM EDT
1.990
+0.010 (0.51%)
After-hours: Oct 8, 2025, 7:40 PM EDT

TScan Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
11217227937107-
Upgrade
Market Cap Growth
-59.21%-38.39%647.03%-65.09%--
Upgrade
Enterprise Value
-9-9150-66-69-
Upgrade
Last Close Price
1.983.045.831.554.50-
Upgrade
PS Ratio
16.1461.0013.252.7610.54-
Upgrade
PB Ratio
0.640.711.850.380.67-
Upgrade
P/TBV Ratio
0.640.711.850.380.67-
Upgrade
EV/Sales Ratio
--7.14---
Upgrade
Debt / Equity Ratio
0.550.400.610.870.040.43
Upgrade
Asset Turnover
0.020.010.090.070.090.02
Upgrade
Quick Ratio
6.968.076.446.947.561.99
Upgrade
Current Ratio
7.068.146.517.177.762.09
Upgrade
Return on Equity (ROE)
-63.33%-65.08%-71.29%-50.90%-54.64%-87.44%
Upgrade
Return on Assets (ROA)
-26.77%-26.20%-24.79%-21.51%-25.56%-33.08%
Upgrade
Return on Capital (ROIC)
-29.09%-28.97%-27.25%-23.65%-31.75%-45.49%
Upgrade
Earnings Yield
-121.73%-74.22%-32.00%-177.43%-45.48%-
Upgrade
FCF Yield
-116.81%-66.74%-23.14%-189.50%-54.82%-
Upgrade
Buyback Yield / Dilution
-7.21%-18.32%-98.89%-106.20%-1173.20%-137.86%
Upgrade
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q